���ӽ紫ý

Local experts Cameron Belt, the senior economist and research director for RCG Economics, and Shawn McCoy, Ph.D., director of the Lied Center for Real Estate at ���ӽ紫ý, will analyze and discuss potential solutions to this critical issue facing our community.

A month into the second quarter, a ���ӽ紫ý survey shows Southern Nevada business leaders entered the period with sharply diminished confidence, as the regional index fell nearly 32 points from the first quarter amid concerns about the national economy, ongoing geopolitical tensions and persistent hiring weakness.

A Wellness Corral will be hosted by Osher Lifelong Learning Institute at ���ӽ紫ý, where attendees can explore activities such as ukulele lessons, Mahjong, art tables, and puzzle and board game strategies.

The federal government’s restrictive control of a fair chunk of the remaining land left for development in the Las Vegas Valley is now weighing heavily on the region’s housing market, according to multiple sources.

Experts across gaming, cannabis policy, and state government say expanding access to legal, regulated cannabis in Las Vegas could help bolster tourism and support the broader gaming industry, particularly as visitation trends soften and competition for consumer spending intensifies.

In 2019, researchers at ���ӽ紫ý, the University of San Diego and Amsterdam University reported that about 99% of Alzheimer’s clinical trials had failed. After decades of setbacks, however, newer treatments are beginning to show success in clinical trials and are now moving through regulatory review. Scientists say these incremental advances could start to shift the trajectory of the disease, even as the number of people diagnosed continues to grow.

Las Vegas medical school study shows 35% increase in clinical trials since 2016.

It’s a chance for engineering students to showcase their creativity at ���ӽ紫ý’s senior design competition. They are thinking outside the box and focusing on sustainability and water conservation.

The U.S. Supreme Court restored broad access to the abortion pill Mifepristone, at least for now, allowing women to obtain the medication at pharmacies, through telehealth or through the mail without an in-person visit to a doctor.